CLOs on the Move

M Jacobson Usa

www.mediprime.com

 
M Jacobson Usa is a Los Angeles, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million

Executives

Name Title Contact Details

Similar Companies

Sinclair Pharmaceuticals

Sinclair Pharmaceuticals, Ltd. is a Carrollton, TX-based company in the Healthcare, Pharmaceuticals, & Biotech sector.

Nihon Kohden America

Nihon Kohden America is a global leader and fast-growing manufacturer of instrumentation for Patient Monitoring, Sleep Assessment, Neurology and Cardiology. Our relentless dedication to quality, customer support with heart, and employee development are what makes us unique.

Five Star Surgical

Five Star Surgical, Inc. is a New Bedford, MA-based company in the Healthcare, Pharmaceuticals, & Biotech sector.

NOWDiagnostics

NOWDiagnostics Inc., based in Springdale, Ark., is a leader in innovative diagnostics testing. Its ADEXUSDx™ product line features a lab at your fingertip, using only a single drop of blood to test for a variety of common conditions, illnesses and diseases with results in a matter of minutes. By eliminating the need to send tests to off-site laboratories, NOWDiagnostics has the potential to decrease by days the waiting period to determine test results. The company is currently offering an hCG (pregnancy) test in the United States and Europe, and two cardiac (heart attack) tests and three toxicology tests in Europe. Additional tests are in the development pipeline, including sexually transmitted diseases, more cardiac (heart attack), food intolerances, common infectious diseases and a variety of screening tests.

RF Surgical Systems

RF Surgical Systems, Inc. is a medical device company with headquarters in Bellevue, Washington and engineering R & D facilities in San Diego, California. The advanced technologies used in the RF Surgical Detection System are protected by U.S. patents. Regulatory clearance to market the system was granted by the U.S. Food and Drug Administration in November of 2006